OPTOCODE · In vivo assessment of the optical cochlear implant performance: coding strategy optimization
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2023-09-01 → 2025-11-30
- EU contribution
- €173,847
- Participants
- 1
- Scheme
- HORIZON-TMA-MSCA-PF-EF
Lines connect the coordinator with its partners.
Results in brief
In vivo assessment of the optical cochlear implant performance: coding strategy optimization
Hearing loss affects millions of people worldwide, significantly impacting communication, quality of life, and social inclusion. Traditional cochlear implants (CIs), which electrically stimulate the auditory nerve, provide substantial benefits for individuals with severe hearing loss. However, electrical stimulation spreads across a broad area of the auditory nerve, limiting the number of perceptual channels and reducing the resolution of complex sounds such as speech in noisy environments. This constrains pitch perception and speech understanding in challenging listening conditions. Optogenetics offers an innovative solution to these limitations. Optical cochlear implants (oCIs) can stimulate auditory neurons with light, which can be confined more precisely than electrical currents. This allows for reduced spread of excitation, higher frequency selectivity, and potentially a greater number of perceptual channels. Consequently, oCIs have the potential to improve sound resolution, pitch perception, and speech understanding, addressing key unmet needs in hearing restoration. The OPTOCODE project aimed to advance the development of oCIs by optimizing their coding strategies. The project’s original objectives were: O1: Develop a non-invasive method to determine the frequency mapping of implanted oCIs in animal models. O2: Optimize the encoding strategy of the optical cochlear implant. Specifically, the OPTOCODE project aimed to implement a cross-modal optimization framework to decipher the optical coding strategy for oCIs. This approach was designed to combine predictive models of acoustic-evoked and optical-evoked responses in the inferior colliculus (IC) to ultimately map sound waveforms to the optical emitters of the oCI and derive optimized stimulation strategies. The expected impacts of the project are both scientific and translational. By establishing a framework for optimizing optical stimulation of the auditory nerve, OPTOCODE aims to advance the development of oCIs with higher spectral resolution, potentially improving pitch perception, speech understanding in noisy environments, and overall quality of life for CI users. Strategically, the project aligns with European priorities for innovation in neurotechnology and medical devices and addresses societal challenges related to sensory impairments.
Data: CORDIS, © European Union
Project objective
Hearing loss affects millions of people worldwide. In cases of pronounced cochlear dysfunction, an electrical cochlear implant (eCI) can partially restore hearing sensation by electrically stimulating the auditory nerve. Until now, the eCI is the most successful and broadly used neuroprosthesis, with more than 1 million users worldwide (WHO, 2021). However, eCI hearing is far from normal: eCI users can typically not comprehend speech in noisy environments, because the electrical signal spreads widely and excites a large number of neurons of the auditory nerve, which limits the number of separate perceptual channels.Using optogenetics, it is possible to stimulate the auditory nerve using an optical cochlear implant (oCI). As light spread can be better confined in space, oCIs offer lower spread of excitation and, hence, greater frequency selectivity. This way, future clinical oCIs promise more perceptual channels, allowing for more pitch appreciation and better understanding of speech in noise. However, there are many challenges in the development of the oCI en route to clinical application. Importantly, we are currently missing a holistic assessment tool for preclinical efficacy which could serve oCI optimization. I will develop a set of methodological and computational tools to assess the oCI performance in vivo, in the Mongolian gerbil. First, I will use the brainstem responses to map the frequency activation of separate optical channels. Second, I will develop predictive models that derive the optogenetically and acoustically evoked responses of the midbrain, applying machine learning techniques. Third, I will use the above-mentioned tools to identify the optimal coding strategy for the oCI. This project will accelerate the development of the oCI, and provide benchmarking standards for the clinical trials of optical neural implants.
Original text from CORDIS.
Participants
- UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS · GoettingenCoordinatorGermany
Links
- View on CORDIS
- DOI: 10.3030/101107675
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e527a9c51f&appId=PPGMS
Data: CORDIS, © European Union
